Ryan Maynard

Insider Reports History

Entity
Individual
Location
Rigel Pharmaceuticals, Inc., 1180 Veterans Blvd., South San Francisco, CA
Signature
/s/ Ryan Maynard
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ryan Maynard:

Stock Role Class Num Shares Value Price $ Report Date Ownership
IOVANCE BIOTHERAPEUTICS, INC. Director Deferred Restricted Stock Unit 49.3K $413K $8.37 Jun 11, 2024 Direct
IOVANCE BIOTHERAPEUTICS, INC. Director Common Stock 7.5K $75.5K $10.06 Nov 12, 2024 Direct
Cara Therapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 13.5K $7.43K $0.55 Feb 1, 2024 Direct
Cara Therapeutics, Inc. CHIEF FINANCIAL OFFICER Stock Option (Right to Buy) 81K Mar 1, 2023 Direct
IOVANCE BIOTHERAPEUTICS, INC. Director Stock Option (right to buy) 0 Nov 12, 2024 Direct

Insider Reports Filed by Ryan Maynard

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IOVA IOVANCE BIOTHERAPEUTICS, INC. Nov 12, 2024 3 -$131K 4 Nov 14, 2024 Director
IOVA IOVANCE BIOTHERAPEUTICS, INC. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
IOVA IOVANCE BIOTHERAPEUTICS, INC. Mar 1, 2024 1 $0 4 Mar 5, 2024 Director
CARA Cara Therapeutics, Inc. Feb 8, 2024 1 -$2.91K 4 Feb 12, 2024 CHIEF FINANCIAL OFFICER
CARA Cara Therapeutics, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 CHIEF FINANCIAL OFFICER
IOVA IOVANCE BIOTHERAPEUTICS, INC. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
CARA Cara Therapeutics, Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 Chief Financial Officer
CARA Cara Therapeutics, Inc. Sep 12, 2022 1 $0 4 Sep 14, 2022 Chief Financial Officer
CARA Cara Therapeutics, Inc. Sep 12, 2022 0 $0 3 Sep 14, 2022 Chief Financial Officer
IOVA IOVANCE BIOTHERAPEUTICS, INC. Jun 10, 2022 1 $0 4 Jun 14, 2022 Director
IOVA IOVANCE BIOTHERAPEUTICS, INC. May 31, 2022 1 $50.6K 4 Jun 2, 2022 Director
IOVA IOVANCE BIOTHERAPEUTICS, INC. Jun 29, 2021 1 $0 4 Jul 1, 2021 Director